{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:34:48Z","timestamp":1790436888177,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jsbmb.2013.04.009","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T19:01:19Z","timestamp":1368817279000},"page":"18-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["In silico methods in the discovery of endocrine disrupting chemicals"],"prefix":"10.1016","volume":"137","author":[{"given":"Anna","family":"Vuorinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Odermatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2013.04.009_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/er.2009-0002","article-title":"Endocrine-disrupting chemicals: an endocrine society scientific statement","volume":"30","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Endocrine Reviews"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.04.009_bib0010","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/er.2011-1050","article-title":"Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses","volume":"33","author":"Vandenberg","year":"2012","journal-title":"Endocrine Reviews"},{"issue":"1","key":"10.1016\/j.jsbmb.2013.04.009_bib0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2605.2005.00561.x","article-title":"Endocrine disrupters and human puberty","volume":"29","author":"Den Hond","year":"2006","journal-title":"International Journal of Andrology"},{"issue":"1","key":"10.1016\/j.jsbmb.2013.04.009_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfl051","article-title":"The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals","volume":"94","author":"Sanderson","year":"2006","journal-title":"Toxicological Sciences"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.04.009_bib0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2605.2008.00899.x","article-title":"Is hypospadias a genetic, endocrine or environmental disease, or still an unexplained malformation?","volume":"32","author":"Kalfa","year":"2009","journal-title":"International Journal of Andrology"},{"issue":"12","key":"10.1016\/j.jsbmb.2013.04.009_bib0030","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.3390\/molecules16129983","article-title":"Inhibitors of testosterone biosynthetic and metabolic activation enzymes","volume":"16","author":"Ye","year":"2011","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.04.009_bib0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cbi.2011.12.008","article-title":"Effects of phthalates on 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 activities in human and rat testes","volume":"195","author":"Yuan","year":"2012","journal-title":"Chemico-Biological Interactions"},{"issue":"1\u20135","key":"10.1016\/j.jsbmb.2013.04.009_bib0040","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsbmb.2006.09.010","article-title":"Disruption of glucocorticoid action by environmental chemicals: potential mechanisms and relevance","volume":"102","author":"Odermatt","year":"2006","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"10","key":"10.1016\/j.jsbmb.2013.04.009_bib0045","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.bcp.2008.07.019","article-title":"Glucocorticoid and mineralocorticoid action: why should we consider influences by environmental chemicals?","volume":"76","author":"Odermatt","year":"2008","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2012.10.002","article-title":"Inhibition of human and rat 11beta-hydroxysteroid dehydrogenases activities by bisphenol A","author":"Guo","year":"2012","journal-title":"Toxicology letters"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0055","first-page":"52","article-title":"Endocrine-disrupting chemicals: associated disorders and mechanisms of action","author":"De Coster","year":"2012","journal-title":"Journal of Environment and Public Health"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0060","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1476-069X-11-S1-S8","article-title":"Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain","volume":"11","author":"Fucic","year":"2012","journal-title":"Environmental Health"},{"issue":"74\u201382","key":"10.1016\/j.jsbmb.2013.04.009_bib0065","article-title":"Disruption of androgen receptor signaling in males by environmental chemicals","volume":"127","author":"Luccio-Camelo","year":"2011","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1677\/joe.0.1580327","article-title":"Several environmental oestrogens are also anti-androgens","volume":"158","author":"Sohoni","year":"1998","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2009.02.017","article-title":"PPAR-mediated activity of phthalates: a link to the obesity epidemic?","volume":"304","author":"Desvergne","year":"2009","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0080","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20120042","article-title":"The endocrine disruptor monoethyl-hexyl-phthalate promotes adipocyte differentiation and induces obesity in mice","author":"Hao","year":"2012","journal-title":"Bioscience Reports"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0085","first-page":"144","article-title":"Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behavious and neuroendocrine systems","volume":"24","author":"Frye","year":"2011","journal-title":"Journal of Endocrinology"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.04.009_bib0090","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","article-title":"Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta","volume":"138","author":"Kuiper","year":"1997","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jsbmb.2013.04.009_bib0095","doi-asserted-by":"crossref","first-page":"e31109","DOI":"10.1371\/journal.pone.0031109","article-title":"Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor beta","volume":"7","author":"Soriano","year":"2012","journal-title":"PLoS One"},{"issue":"37","key":"10.1016\/j.jsbmb.2013.04.009_bib0100","doi-asserted-by":"crossref","first-page":"14930","DOI":"10.1073\/pnas.1203574109","article-title":"Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes","volume":"109","author":"Delfosse","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.jsbmb.2013.04.009_bib0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.toxlet.2006.11.016","article-title":"Estrogens and antiestrogens activate hPXR","volume":"170","author":"Mnif","year":"2007","journal-title":"Toxicology Letters"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.04.009_bib0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1289\/ehp.1104426","article-title":"Bisphenol A and its analogues activate human pregnane X receptor","volume":"120","author":"Sui","year":"2012","journal-title":"Environmental Health Perspectives"},{"issue":"9","key":"10.1016\/j.jsbmb.2013.04.009_bib0115","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1289\/ehp.1003328","article-title":"Peroxisome proliferator-activated receptor gamma is a target for halogenated analogs of bisphenol A","volume":"119","author":"Riu","year":"2011","journal-title":"Environmental Health Perspectives"},{"issue":"2","key":"10.1016\/j.jsbmb.2013.04.009_bib0120","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/toxsci\/kfr132","article-title":"Characterization of novel ligands of ERalpha, ERbeta, and PPARgamma: the case of halogenated bisphenol A and their conjugated metabolites","volume":"122","author":"Riu","year":"2011","journal-title":"Toxicological Sciences"},{"issue":"2","key":"10.1016\/j.jsbmb.2013.04.009_bib0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/toxsci\/kfr312","article-title":"Parallel biotransformation of tetrabromobisphenol A in Xenopus laevis and mammals: Xenopus as a model for endocrine perturbation studies","volume":"125","author":"Fini","year":"2012","journal-title":"Toxicological Sciences"},{"issue":"11","key":"10.1016\/j.jsbmb.2013.04.009_bib0130","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1210\/jc.2002-020209","article-title":"Thyroid hormone action is disrupted by bisphenol A as an antagonist","volume":"87","author":"Moriyama","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.04.009_bib0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/me.2010-0284","article-title":"Minireview: extranuclear steroid receptors: roles in modulation of cell functions","volume":"25","author":"Levin","year":"2011","journal-title":"Molecular Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2013.04.009_bib0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mce.2003.09.027","article-title":"A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity","volume":"212","author":"Schweizer","year":"2003","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"2","key":"10.1016\/j.jsbmb.2013.04.009_bib0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.toxlet.2011.09.001","article-title":"Inhibition of human and rat testicular steroidogenic enzyme activities by bisphenol A","volume":"207","author":"Ye","year":"2011","journal-title":"Toxicology letters"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0150","first-page":"1","article-title":"The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11\u03b2-hydyroxysteroid dehydrogenase type 1 in the adipose tissue of children","author":"Wang","year":"2012","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.111.095349","article-title":"The industrial chemical Bisphenol A (BPA) interferes with proliferative activity and development of steroidogenic capacity in rat Leydig cells","volume":"86","author":"Nanjappa","year":"2012","journal-title":"Biology of Reproduction"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0160","article-title":"The holistic integration of virtual screening in drug discovery","volume":"00","author":"Tanrikulu","year":"2013","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0165","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1021\/jm010548w","article-title":"Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B","volume":"45","author":"Doman","year":"2002","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0170","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1016\/j.bmc.2010.05.071","article-title":"Morphinans and isoquinolines: acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptors","volume":"18","author":"Schuster","year":"2010","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0175","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1351\/pac199870051129","article-title":"Glossary of terms used in medicinal chemistry (IUPAC recommendations)","volume":"70","author":"Wermuth","year":"1998","journal-title":"Pure & Applied Chemistrty"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0180","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/0958-1669(95)80107-3","article-title":"Docking small-molecule ligands into active sites","volume":"6","author":"Jones","year":"1995","journal-title":"Current Opinion in Biotechnology"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0185","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1021\/jm040163o","article-title":"A shape-based 3-D Scaffold Hopping method and its application to a bacterial protein\u2013protein interaction","volume":"48","author":"Rush","year":"2005","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjp.0707305","article-title":"In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling","volume":"152","author":"Ekins","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"Keiser","year":"2007","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10629360601054032","article-title":"PASS: identification of probable targets and mechanisms of toxicity","volume":"18","author":"Poroikov","year":"2007","journal-title":"SAR and QSAR in Environmental Research"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jsbmb.2010.12.013","article-title":"17b-Hydroxysteroid dehydrogenases (17\u03b2-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development","volume":"125","author":"Marchais-Oberwinkler","year":"2011","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0210","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.bcp.2009.12.005","article-title":"The UV-filter benzophenone-1 inhibits 17\u03b2-hydroxysteroid dehydrogenase type 3: virtual screening as a strategy to identify potential endocrine disrupting chemicals","volume":"79","author":"Nashev","year":"2010","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0215","doi-asserted-by":"crossref","first-page":"e46958","DOI":"10.1371\/journal.pone.0046958","article-title":"Virtual screening as a strategy for the identification of xenobiotics disrupting corticosteroid action","volume":"7","author":"Nashev","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0220","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1021\/jm0600794","article-title":"The discovery of new 11\u03b2-hydroxysteroid dehydrogenase Type 1 inhibitors by common feature pharmacophore modeling and virtual screening","volume":"49","author":"Schuster","year":"2006","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0225","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1021\/tx0601509","article-title":"QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles","volume":"19","author":"Liu","year":"2006","journal-title":"Chemical Research in Toxicology"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0230","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1021\/ci100078u","article-title":"Classification and virtual screening of androgen receptor antagonists","volume":"50","author":"Li","year":"2010","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"3","key":"10.1016\/j.jsbmb.2013.04.009_bib0235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.14573\/altex.2009.3.167","article-title":"VirtualToxLab \u2013 in silico prediction of the toxic (endocrine-disrupting) potential of drugs, chemicals and natural products. Two years and 2,000 compounds of experience: a progress report","volume":"26","author":"Vedani","year":"2009","journal-title":"Altex"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0240","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1021\/tx060218k","article-title":"Identification of previously unrecognized antiestrogenic chemicals using a novel virtual screening approach","volume":"19","author":"Wang","year":"2006","journal-title":"Chemical Research in Toxicology"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1025361621494","article-title":"In silico prediciton of drug toxicity","volume":"17","author":"Dearden","year":"2003","journal-title":"Journal of Computer Aided Molecular Designing"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157016306776637609","article-title":"Development and validation of an in silico p450 profiler based on pharmacophore models","volume":"3","author":"Schuster","year":"2006","journal-title":"Current Drug Discovery Technologies"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0255","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1021\/jm900817u","article-title":"Three-dimensional pharmacophore methods in drug discovery","volume":"53","author":"Leach","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"issue":"8","key":"10.1016\/j.jsbmb.2013.04.009_bib0260","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jmgm.2008.01.002","article-title":"The importance of the domain of applicability in QSAR modeling","volume":"26","author":"Weaver","year":"2008","journal-title":"Journal of Molecular Graphics and Modelling"},{"issue":"4","key":"10.1016\/j.jsbmb.2013.04.009_bib0265","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.ddtec.2010.12.003","article-title":"Docking compared to 3D-pharmacophores: the scoring function challenge","volume":"7","author":"Hein","year":"2010","journal-title":"Current Drug Discovery Technologies"},{"issue":"2","key":"10.1016\/j.jsbmb.2013.04.009_bib0270","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-291X(03)01359-7","article-title":"Inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 2 by dithiocarbamates","volume":"308","author":"Atanasov","year":"2003","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1\u20133","key":"10.1016\/j.jsbmb.2013.04.009_bib0275","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tox.2012.07.001","article-title":"Species-specific differences in the inhibition of human and zebrafish 11beta-hydroxysteroid dehydrogenase 2 by thiram and organotins","volume":"301","author":"Meyer","year":"2012","journal-title":"Toxicology"},{"issue":"10","key":"10.1016\/j.jsbmb.2013.04.009_bib0280","doi-asserted-by":"crossref","first-page":"e3545","DOI":"10.1371\/journal.pone.0003545","article-title":"Dibutyltin disrupts glucocorticoid receptor function and impairs glucocorticoid-induced suppression of cytokine production","volume":"3","author":"Gumy","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0285","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/qsar.19960150405","article-title":"Quantum-chemical descriptors for estimating the acute toxicity of electrophiles to the fathed minnow (Pimephales promelas): an analysis based on molecular mechanisms","volume":"15","author":"Karabunarliev","year":"1996","journal-title":"Quantitative Structure-activity Relationships"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0290","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.1021\/jm301008n","article-title":"Rules for identifying potentially reactive or promiscuos compounds","volume":"55","author":"Bruns","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"issue":"9","key":"10.1016\/j.jsbmb.2013.04.009_bib0295","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1021\/ci300196g","article-title":"Structural insights into the molecular basis of the ligand promiscuity","volume":"52","author":"Sturm","year":"2012","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0300","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/ci100136b","article-title":"One concept, three implementations of 3D pharmacophore-based virtual screening: distinct coverage of chemical search space","volume":"50","author":"Spitzer","year":"2010","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"5","key":"10.1016\/j.jsbmb.2013.04.009_bib0305","doi-asserted-by":"crossref","first-page":"e11955","DOI":"10.1371\/journal.pone.0011955","article-title":"Virtual screening for HIV protease inhibitors: a comparison of AutoDock4 and Vina","volume":"2","author":"Chang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0310","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/0929867003375317","article-title":"Molecular modeling and computer aided drug design. Examples of their application in medicinal chemistry","volume":"7","author":"Ooms","year":"2000","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.jsbmb.2013.04.009_bib0315","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1517\/13543776.2010.505604","article-title":"17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review","volume":"20","author":"Poirier","year":"2010","journal-title":"Expert Opinion on Therapeutic Patents"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076013000733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076013000733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:46:39Z","timestamp":1760744799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076013000733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":63,"alternative-id":["S0960076013000733"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2013.04.009","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico methods in the discovery of endocrine disrupting chemicals","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2013.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}